These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11035928)

  • 1. F9 embryonal carcinoma cells engineered for tamoxifen-dependent Cre-mediated site-directed mutagenesis and doxycycline-inducible gene expression.
    Chiba H; Chambon P; Metzger D
    Exp Cell Res; 2000 Nov; 260(2):334-9. PubMed ID: 11035928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site- and time-specific gene targeting in the mouse.
    Metzger D; Chambon P
    Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse.
    Hayashi S; McMahon AP
    Dev Biol; 2002 Apr; 244(2):305-18. PubMed ID: 11944939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal control of Cre recombinase-mediated in vitro DNA recombination by Tet-on gene expression system.
    Guo ZM; Xu K; Yue Y; Huang B; Deng XY; Zhong NQ; Hong X; Chen XG; Xiao D
    Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):133-8. PubMed ID: 15685371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice.
    Utomo AR; Nikitin AY; Lee WH
    Nat Biotechnol; 1999 Nov; 17(11):1091-6. PubMed ID: 10545915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell type-specific conditional regulation of the c-myc proto-oncogene by combining Cre/loxP recombination and tamoxifen-mediated activation.
    Jäger R; Maurer J; Jacob A; Schorle H
    Genesis; 2004 Mar; 38(3):145-50. PubMed ID: 15048812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible gene inactivation in neurons of the adult mouse forebrain.
    Erdmann G; Schütz G; Berger S
    BMC Neurosci; 2007 Aug; 8():63. PubMed ID: 17683525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetracycline-inducible gene expression and gene deletion in Candida albicans.
    Park YN; Morschhäuser J
    Eukaryot Cell; 2005 Aug; 4(8):1328-42. PubMed ID: 16087738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocyte cell-specific expression of doxycycline inducible Cre recombinase in mice.
    Juhila J; Roozendaal R; Lassila M; Verbeek SJ; Holthofer H
    J Am Soc Nephrol; 2006 Mar; 17(3):648-54. PubMed ID: 16467448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction.
    Belteki G; Haigh J; Kabacs N; Haigh K; Sison K; Costantini F; Whitsett J; Quaggin SE; Nagy A
    Nucleic Acids Res; 2005 Mar; 33(5):e51. PubMed ID: 15784609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible transgenic mouse models.
    Saunders TL
    Methods Mol Biol; 2011; 693():103-15. PubMed ID: 21080277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of Cre recombinase toxicity in proliferating Drosophila cells by estrogen-dependent activity regulation.
    Heidmann D; Lehner CF
    Dev Genes Evol; 2001 Sep; 211(8-9):458-65. PubMed ID: 11685583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Floxed reporter genes: Flow-cytometric selection of clonable cells expressing high levels of a target gene after tamoxifen-regulated Cre-loxP recombination.
    Spiotto MT; Schreiber H
    J Immunol Methods; 2006 May; 312(1-2):201-8. PubMed ID: 16674971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanosoma brucei: a first-generation CRE-loxP site-specific recombination system.
    Barrett B; LaCount DJ; Donelson JE
    Exp Parasitol; 2004; 106(1-2):37-44. PubMed ID: 15013787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional gene activation in cultured hepatocytes using a ligand-dependent chimeric Cre recombinase.
    Zhu HZ; Cao YY; Cheng GX; Xue JL
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 May; 35(5):435-40. PubMed ID: 12766804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible site-specific recombination in the brain.
    Kellendonk C; Tronche F; Casanova E; Anlag K; Opherk C; Schütz G
    J Mol Biol; 1999 Jan; 285(1):175-82. PubMed ID: 9878397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen-inducible Cre-mediated recombination in adipocytes.
    Sassmann A; Offermanns S; Wettschureck N
    Genesis; 2010 Oct; 48(10):618-25. PubMed ID: 20715175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tamoxifen-inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver.
    Tannour-Louet M; Porteu A; Vaulont S; Kahn A; Vasseur-Cognet M
    Hepatology; 2002 May; 35(5):1072-81. PubMed ID: 11981757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A practical summary of site-specific recombination, conditional mutagenesis, and tamoxifen induction of CreERT2.
    Anastassiadis K; Glaser S; Kranz A; Berhardt K; Stewart AF
    Methods Enzymol; 2010; 477():109-23. PubMed ID: 20699139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.